Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.

中文翻译：

---

针对SARS-CoV-2和其他人类冠状病毒的中和抗体。

由严重急性呼吸系统综合症（SARS）-CoV-2（也称为2019-nCoV）引起的冠状病毒（CoV）疾病2019（COVID-19）正在威胁全球公共卫生，社会稳定和经济发展。为了应对这一挑战，本文讨论了用于预防和治疗SARS-CoV-2和其他人类CoV感染的中和抗体（nAb）的研究和开发进展。